Comparative Study Between Intravenous Lignocaine & Intravenous Dexmedetomidine For Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Main Article Content
Keywords
Dexmedetomidine, Lignocaine, Hemodynamic response, Laryngoscopy, Endotracheal intubation, Blood pressure, Heart rate etc.
Abstract
Laryngoscopy and endotracheal intubation are essential components of General Anaesthesia but are associated with a sympathetic surge, resulting in significant hemodynamic changes such as tachycardia and hypertension. These transient changes, although often well tolerated in healthy individuals, may pose serious risks in patients with cardiovascular or cerebrovascular comorbidities. Various pharmacological agents have been used to blunt this response, among which dexmedetomidine and lignocaine are frequently employed. This study aimed to compare the efficacy of intravenous lignocaine and intravenous dexmedetomidine in attenuating the hemodynamic responses to laryngoscopy and endotracheal intubation in adult patients undergoing elective surgeries under General Anaesthesia.
Materials and Methods:
A prospective, randomized, clinical study was conducted at ICARE Institute of Medical Sciences and Research & Dr. B. C. Roy Hospital, Haldia, West Bengal, over a one-year period from July 2023 to June 2024. A total of 100 patients (ASA I & II), aged 18–60 years, were randomly divided into two groups: Group L received intravenous lignocaine (1.5 mg/kg, 3 minutes before intubation) while Group D received intravenous dexmedetomidine (1 µg/kg over 10 minutes before induction). Hemodynamic parameters such as heart rate (HR), systolic blood pressure (SBP), and mean arterial pressure (MAP) were recorded at baseline, induction, intubation, and at 1, 3, 5, and 10 minutes post-intubation.
Results:
Group D (Dexmedetomidine) showed a statistically significant attenuation of heart rate, systolic blood pressure and mean arterial pressure at induction and during the first five minutes post-intubation compared to Group L (Lignocaine), with p-values <0.001 across most time points. At intubation, the mean heart rate in Group D was 72.58 bpm versus 84.28 bpm in Group L, and mean SBP was 104.70 mmHg in Group D versus 120.16 mmHg in Group L. MAP values followed a similar trend, with Group D demonstrating consistently lower readings. No severe bradycardia, hypotension, or delayed emergence was noted in either group. The dexmedetomidine group also showed a smoother anesthetic induction and better peri-intubation cardiovascular stability, reinforcing its efficacy and safety profile in mitigating intubation-induced stress responses.
Conclusion:
Dexmedetomidine is significantly more effective than lignocaine in attenuating the hemodynamic response to laryngoscopy and intubation, making it a safer and more reliable choice, especially in patients at cardiovascular risk.
References
2. Shribman AJ, Smith G, Achola KJ. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth. 1987;59(3):295–299.
3. Prys-Roberts C, Greene LT, Meloche R, Foëx P. Studies of anaesthesia in relation to hypertension: II. Hemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. 1971;43(6):531–547.
4. Fox EJ, Sklar GS, Hill CH, Villanueva R, King BD. Complications related to the pressor response to endotracheal intubation. Anesthesiology. 1977;47(6):524–525.
5. Derbyshire DR, Chmielewski A, Fell D, Vater M, Achola K, Smith G. Plasma catecholamine responses to tracheal intubation. Br J Anaesth. 1983;55(9):855–860.
6. Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: Influence of duration of laryngoscopy with or without prior lidocaine. Anesthesiology. 1977;47(4):381–384.
7. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13–21.
8. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77(6):1125–1133.
9. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Comparison of dexmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesthesiology. 1991;74(5):827–831.
10. Bromage PR. Attenuation of pressor responses to laryngoscopy with intravenous lidocaine. Br J Anaesth. 1961;33(12):778.
11. R. Lev, D. W. Rosen, T. C. Carstairs. Lidocaine for airway management: a review. Ann Emerg Med. 1994;23(6):1319–1323.
12. Keniya VM, Ladi SD, Naphade RW. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and decreases requirement of opioids and anaesthetics. Indian J Anaesth. 2011;55(4):352–357.
13. Srivastava VK, Agrawal S, Kumar S, Sharma S, Kumar R. Dexmedetomidine versus midazolam and propofol for sedation in neurosurgical patients: A comparative evaluation. J Anaesthesiol Clin Pharmacol. 2014;30(1):60–64.
14. Ghosh S, Kundu A, Ghosh M, Chatterjee N. Dexmedetomidine: A short review. J Anaesth Clin Pharmacol. 2011;27(4):515–520.
15. Kovac AL. Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. J Clin Anesth. 1996;8(1):63–79.
16. Shribman AJ, Smith G, Achola KJ. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth. 1987;59(3):295–299.
17. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. Anesthesiology. 1992;77(6):1125–1133.
18. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 2000;93(5):1345–1349.
19. Bajwa SJ, Arora V, Kaur J, Singh A, Parmar SS. Comparative evaluation of dexmedetomidine and fentanyl for attenuation of hemodynamic stress response to laryngoscopy and intubation. Int J Crit Illn Inj Sci. 2012;2(1):25–29.
20. Patel CR, Engineer SR, Shah BJ, Madhu S. Effect of intravenous dexmedetomidine on perioperative hemodynamic changes and postoperative recovery: A study with entropy analysis. Indian J Anaesth. 2012;56(6):542–546.
21. Tanskanen PE, Kyttä JV, Randell TT, Aantaa RE. Dexmedetomidine as an anesthetic adjuvant in patients undergoing intracranial tumor surgery: A double-blind, randomized, controlled study. Br J Anaesth. 2006;97(5):658–665.
22. Yavascaoglu B, Kaya FN, Baykara M, et al. Effectiveness of dexmedetomidine versus lidocaine in blunting the hemodynamic response to laryngoscopy and endotracheal intubation: A prospective, randomized, double-blind study. Curr Ther Res Clin Exp. 2007;68(4):292–302.
23. Sharma VS, Kumari I, Shah PJ. Comparative evaluation of intravenous dexmedetomidine and lidocaine for attenuation of the pressor response to laryngoscopy and intubation. Anesth Essays Res. 2020;14(2):276–281.
24. Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90(4):834–839.
25. Kumari I, Gupta R, Sharma V. Comparison of dexmedetomidine and fentanyl for attenuation of stress response to laryngoscopy and endotracheal intubation. J Anaesthesiol Clin Pharmacol. 2019;35(3):377–381.
26. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90(3):699–705.
27. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Anaesthesia. 1999;54(2):146–165.
28. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98(1):153–158.
29. Snapir A, Posti J, Kentala E, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology. 2006;105(5):902–910.